Key Highlights
•
A new review highlights that Cushing syndrome, caused by too much cortisol, is often missed because its symptoms are common and testing is tricky. This means better ways to track a patient’s daily cortisol rhythm could lead to earlier diagnosis and more personalized treatment.
Source →
•
A large study of patients with heart failure and type 2 diabetes found that the drug finerenone can help prevent new diabetes cases and reduce heart failure events. This shows finerenone is a powerful tool for managing the complex link between heart and metabolic health.
Source →
•
A new review discusses how to treat fatty liver disease in people who also have type 2 diabetes, a common and serious combination. This work is crucial because it guides doctors on using the right medications to protect both the liver and the heart in these high-risk patients.
Source →
•
A nationwide study in Japan found that lung cancer patients with pre-existing lung scarring who received immunotherapy lived significantly longer than those who got only chemotherapy, despite a higher risk of lung inflammation from the treatment. This provides strong evidence that immunotherapy can be a life-extending option for this challenging patient group.
Source →
•
A clinical opinion article explains that pelvic venous disorders are a major but often overlooked cause of chronic pelvic pain in women. Raising awareness among gynecologists is key, as working with specialists can lead to proper diagnosis and effective treatment for this debilitating condition.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
